Progress in Platelet-Rich Plasmapheresis in Cardiopulmonary Bypass Cardiac Surgery / 中国医科大学学报

ABSTRACT

Cardiac surgery with cardiopulmonary bypass is prone to severe bleeding and often requires blood product transfusion. However, blood products are limited, expensive, and can cause adverse reactions in recipients. Therefore, in recent years, increased research has been conducted on the use of platelet-rich plasmapheresis in such types of cardiac surgery, to reduce the destruction of the blood from cardiopulmonary bypass and to prevent blood loss.